Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5023-5031

  Lotfi, Ramin ^a   Herzog, Gloria Isabelle ^a   DeMarco, Richard Anthony ^e   Beer Stolz, Donna ^c   Lee, James Joseph ^d   Rubartelli, Anna ^b   Schrezenmeier, Hubert ^a   Lotze, Michael Thomas ^c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e Amnis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOATTRACTANT; EOSINOPHIL PEROXIDASE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN RECEPTOR; MEMBRANE RECEPTOR; PEROXIDE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ARTICLE; BIOLOGICAL ACTIVITY; CELL DAMAGE; CELL DEATH; CELL LYSATE; CELL MIGRATION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DEGRANULATION; DENATURATION; EOSINOPHIL; EOSINOPHIL DEGRANULATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; MOLECULE; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RESPIRATORY BURST; TISSUE INJURY; TISSUE NECROSIS;

ANTIBODIES; ANTIGENS, NEOPLASM; APOPTOSIS; CELL ADHESION; CELL DEGRANULATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; COLORECTAL NEOPLASMS; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHILS; HMGB1 PROTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; NEUTROPHILS; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; RESPIRATORY BURST;

EID: 77954105187     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900504     Document Type: Article

References (39)

1. Lotfi, R., J. J. Lee, and M. T. Lotze. 2007. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J. Immunother. 30: 16-28.
2. Kim, S., H. Takahashi, W. W. Lin, P. Descargues, S. Grivennikov, Y. Kim, J. L. Luo, and M. Karin. 2009. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106.
3. Lotze, M. T., and R. A. DeMarco. 2003. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr. Opin. Investig. Drugs 4: 1405-1409.
4. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5: 331-342.
5. Ito, N., R. A. DeMarco, R. B. Mailliard, J. Han, H. Rabinowich, P. Kalinski, D. B. Stolz, H. J. Zeh, III, and M. T. Lotze. 2007. Cytolytic cells induce HMGB1 release from melanoma cell lines. J. Leukocyte Biol. 81: 75-83.
6. Cormier, S. A., A. G. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. I. Ochkur, K. O'Neill, D. Colbert, et al. 2006. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J. Leukocyte Biol. 79: 1131-1139.
7. Stenfeldt, A. L., and C. Wenneras. 2004. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 112: 605-614.
8. Cuschieri, A., I. C. Talbot, and S. Weeden. 2002. Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br. J. Cancer 86: 674-679.
9. Fernandez-Acenero, M. J., M. Galindo-Gallego, J. Sanz, and A. Aljama. 2000. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 88: 1544-1548.
10. Nagtegaal, I. D., C. A. Marijnen, E. K. Kranenbarg, A. Mulder-Stapel, J. Hermans, C. J. van de Velde, and J. H. van Krieken. 2001. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect: a histopathological and immunohistochemical study. BMC Cancer 1: 7.
11. Nielsen, H. J., U. Hansen, I. J. Christensen, C. M. Reimert, N. Brunner, and F. Moesgaard. 1999. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J. Pathol. 189: 487-495.
12. Pretlow, T. P., E. F. Keith, A. K. Cryar, A. A. Bartolucci, A. M. Pitts, T. G. Pretlow, P. M. Kimball, and E. A. Boohaker. 1983. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res. 43: 2997-3000.
13. Abu-Ghazaleh, R. I., H. Kita, and G. J. Gleich. 1992. Eosinophil activation and function in health and disease. Immunol. Ser. 57: 137-167.
14. Petreccia, D. C., W. M. Nauseef, and R. A. Clark. 1987. Respiratory burst of normal human eosinophils. J. Leukocyte Biol. 41: 283-288.
15. Izuishi, K., A. Tsung, G. Jeyabalan, N. D. Critchlow, J. Li, K. J. Tracey, R. A. DeMarco, M. T. Lotze, M. P. Fink, D. A. Geller, and T. R. Billiar. 2006. Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J. Immunol. 176: 7154-7158.
16. de Oliveira-Marques, V., L. Cyrne, H. S. Marinho, and F. Antunes. 2007. A quantitative study of NF-κB activation by H2O2: relevance in inflammation and synergy with TNF-α. J. Immunol. 178: 3893-3902.
17. Tang, D., Y. Shi, R. Kang, T. Li, W. Xiao, H. Wang, and X. Xiao. 2006. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J. Leukocyte Biol. 81: 741-747.
18. Park, J. S., F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J. Y. Kim, D. Strassheim, J. W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, et al. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. 290: C917-C924.
19. Yu, M., H. Wang, A. Ding, D. T. Golenbock, E. Latz, C. J. Czura, M. J. Fenton, K. J. Tracey, and H. Yang. 2006. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174-179.
20. Jacobsen, E. A., S. I. Ochkur, R. S. Pero, A. G. Taranova, C. A. Protheroe, D. C. Colbert, N. A. Lee, and J. J. Lee. 2008. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J. Exp. Med. 205: 699-710.
21. Lotfi, R., and M. T. Lotze. 2008. Eosinophils induce DC maturation, regulating immunity. J. Leukocyte Biol. 83: 456-460.
22. Huland, E., and H. Huland. 1992. Tumor-associated eosinophilia in interleukin- 2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. J. Cancer Res. Clin Oncol. 118: 463-467.
23. Simon, H. U., S. Plotz, D. Simon, U. Seitzer, L. R. Braathen, G. Menz, A. Straumann, R. Dummer, and F. Levi-Schaffer. 2003. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. Eur. J. Immunol. 33: 834-839.
24. Sosman, J. A., K. Bartemes, K. P. Offord, H. Kita, S. G. Fisher, C. Kefer, T. A. Ellis, R. I. Fisher, T. J. Higgins, and G. J. Gleich. 1995. Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration. Clin. Cancer Res. 1: 805-812.
25. Bianchi, M. 2009. HMGB1 loves company. J Leukocyte Biol. 86: 573-576.
26. Park, J. S., J. Arcaroli, H. K. Yum, H. Yang, H. Wang, K. Y. Yang, K. H. Choe, D. Strassheim, T. M. Pitts, K. J. Tracey, and E. Abraham. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. 284: C870-C879.
27. Someya, A., K. Nishijima, H. Nunoi, S. Irie, and I. Nagaoka. 1997. Study on the superoxide-producing enzyme of eosinophils and neutrophils - comparison of the NADPH oxidase components. Arch. Biochem. Biophys. 345: 207-213.
28. Yagisawa, M., A. Yuo, M. Yonemaru, S. Imajoh-Ohmi, S. Kanegasaki, Y. Yazaki, and F. Takaku. 1996. Superoxide release and NADPH oxidase components in mature human phagocytes: correlation between functional capacity and amount of functional proteins. Biochem. Biophys. Res. Commun. 228: 510-516.
29. Haskell, M. D., J. N. Moy, G. J. Gleich, and L. L. Thomas. 1995. Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood 86: 4627-4637.
30. Moy, J. N., G. J. Gleich, and L. L. Thomas. 1990. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein: effect on superoxide anion generation and lysosomal enzyme release. J. Immunol. 145: 2626-2632.
31. Lee, J. J., and N. A. Lee. 2005. Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin. Exp. Allergy 35: 986-994.
32. Kazama, H., J. E. Ricci, J. M. Herndon, G. Hoppe, D. R. Green, and T. A. Ferguson. 2008. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29: 21-32.
33. Lotze, M. T., H. J. Zeh, A. Rubartelli, L. J. Sparvero, A. A. Amoscato, N. R. Washburn, M. E. Devera, X. Liang, M. Tor, and T. Billiar. 2007. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 220: 60-81.
34. Zeh, H. J., III, and M. T. Lotze. 2005. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J. Immunother. 28: 1-9. (Pubitemid 40075932)
35. Kuchler, A. M., J. Pollheimer, J. Balogh, J. Sponheim, L. Manley, D. R. Sorensen, P. M. De Angelis, H. Scott, and G. Haraldsen. 2008. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am. J. Pathol. 173: 1229-1242.
36. Lanier, L. L. 2009. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 227: 150-160.
37. Chiang, A. C., and J. Massague. 2008. Molecular basis of metastasis. N. Engl. J. Med. 359: 2814-2823.
38. Lee, J. J., and M. T. Lotze. 2009. Molecular basis of metastasis. N. Engl. J. Med. 360: 1679-1680.
39. Taranova, A. G., D. Maldonado, III, C. M. Vachon, E. A. Jacobsen, H. bdala-Valencia, M. P. McGarry, S. I. Ochkur, C. A. Protheroe, A. Doyle, C. S. Grant, et al. 2008. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res. 68: 8582-8589.